Reckitt, Merck deal is off

Share this article:

Reckitt Benkiser is no longer interested in Merck's over-the-counter business. PM Live says reports indicate Merck may have wanted more than Reckitt was willing to spend for a portfolio of goods that includes items such as Coppertone sunscreen.

PM Live notes that the UK company was not the only interested bidder, and Bayer has also expressed an interest in taking on Merck's OTC unit.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Payment database confounds doctors

ProPublica reports that doctors are struggling with a time-intensive registration process and are getting an error message that CMS says is not an error message.

Gilead's idelalisib hat trick

The FDA greenlighted the drug for three cancers.

Shire expands rare disease reach

A $225-million deal with US biotech ArmaGen gives Shire worldwide commercialization rights to an experimental enzyme replacement therapy.